|
Jun 3
|
Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter
|
|
May 29
|
Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%
|
|
May 22
|
Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner
|
|
May 21
|
AINOS (NASDAQ: AIMD) Signs Long-Form Interview and National TV Commercial Agreement with New to The Street
|
|
Apr 23
|
Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly
|
|
Apr 21
|
Ainos and ugo Complete First Robotic Smell Integration in Japan
|
|
Apr 14
|
Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan
|
|
Mar 13
|
Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose’s Potential in Chip Manufacturing and More
|
|
Mar 11
|
Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing
|
|
Jan 21
|
Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025
|
|
Jan 17
|
Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule
|
|
Oct 7
|
Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA Technologies
|
|
Sep 24
|
Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren’s Syndrome
|
|
Sep 23
|
Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options
|
|
Sep 20
|
Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts
|
|
Jul 23
|
Ainos Enrolls First Subject for Clinical Study of VELDONA-Based Animal FCGS Drug
|
|
Nov 28
|
Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical
|
|
Nov 6
|
Ainos Signs MoU for Contract Clinical Trials to Conduct Clinical Study of Potential New Animal Drug Based on VELDONA
|